Transpact Enterprises (BOM:542765) Debt-to-Equity : 0.06 (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Transpact Enterprises Debt-to-Equity?

Transpact Enterprises's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹0.29 Mil. Transpact Enterprises's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹0.00 Mil. Transpact Enterprises's Total Stockholders Equity for the quarter that ended in Sep. 2023 was ₹4.87 Mil. Transpact Enterprises's debt to equity for the quarter that ended in Sep. 2023 was 0.06.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Transpact Enterprises's Debt-to-Equity or its related term are showing as below:

BOM:542765' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.06 Med: 0.36 Max: 0.73
Current: 0.06

During the past 8 years, the highest Debt-to-Equity Ratio of Transpact Enterprises was 0.73. The lowest was 0.06. And the median was 0.36.

BOM:542765's Debt-to-Equity is ranked better than
77.43% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs BOM:542765: 0.06

Transpact Enterprises Debt-to-Equity Historical Data

The historical data trend for Transpact Enterprises's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transpact Enterprises Debt-to-Equity Chart

Transpact Enterprises Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

Get a 7-Day Free Trial

0.73

0.30

0.36

0.49

0.52

Transpact Enterprises Semi-Annual Data
	Mar16	Mar17	Mar18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial								0.51	0.49	0.46	0.52	0.06

Competitive Comparison of Transpact Enterprises's Debt-to-Equity

For the Medical Devices subindustry, Transpact Enterprises's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Transpact Enterprises's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Transpact Enterprises's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Transpact Enterprises's Debt-to-Equity falls into.

Transpact Enterprises Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Transpact Enterprises's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.785	+	0)	/	5.334
	=	0.52

Transpact Enterprises's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.289	+	0)	/	4.866
	=	0.06

Transpact Enterprises (BOM:542765) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Transpact Enterprises Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Transpact Enterprises's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Transpact Enterprises (BOM:542765) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Transpact Enterprises Ltd (BOM:542765) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Makwana Road, 204, 2nd Floor, Timmy Arcade, Marol, Andheri East, Mumbai, MH, IND, 400059

Website

https://www.transpact.in

Transpact Enterprises Ltd is an Indian company engaged in the manufacture of other medical and dental instruments. It operates only in India.

Transpact Enterprises (BOM:542765) Headlines

No Headlines